Abiopharma

🔍 Cavalcanti Guilherme Perboyre (Executive)

Company: JBS N.V. (JBS)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Sold 183,501 shares of Class A Common Shares at $13.85 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Class A Common Shares, par value (euro)0.01 per share, of the issuer, held in the form of Brazilian Depositary Receipts ("BDRs"). Each BDR represents one Class A Common Share.
• F2: The price reported in Column 4 is a weighted average price per BDR of R$71.35, converted into U.S. dollars, using the selling rate as reported by the Brazilian Central Bank on August 24, 2026 of R$5.1512 to US$1.00. The BDRs were sold in multiple transactions at prices ranging from R$71.00 to R$72.05 (equivalent to US$13.78 to US$13.99, converted into U.S. dollars using the same selling rate). The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• REMARKS: Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.